Atmofizer Technologies Inc. announced that the Company has entered into a non-exclusive distribution agreement with USA Rapid Test, LLC under which USA Rapid Test has placed an initial purchase order for USD 4.2 million personal space, Atmofizer A500s. USA Rapid Test, based out of Clearwater, Florida, is a distributor of COVID-19 rapid tests and distributes to major companies in the healthcare, retail, hospitality, education and entertainment industries. In accordance with terms of the distribution agreement, USA Rapid Test will hold non-exclusive rights to distribute Atmofizer products throughout the United States through online, B2C and B2B channels.